Moolec Science SA (MLEC)

Market Cap	35.87M
Revenue (ttm)	5.01M
Net Income (ttm)	-7.52M
Shares Out	37.56M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,727
Open	0.960
Previous Close	0.940
Day's Range	0.900 - 0.960
52-Week Range	0.770 - 3.250
Beta	-0.55
Analysts	Strong Buy
Price Target	6.00 (+528.27%)
Earnings Date	Sep 18, 2024

About MLEC

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 45
• Stock Exchange: NASDAQ
• Ticker Symbol: MLEC
• Website: https://moolecscience.com

Analyst Forecast

According to one analyst, the rating for MLEC stock is "Strong Buy" and the 12-month stock price forecast is $6.0.

Price Target

$6.0

(528.27% upside)

Analyst Consensus: Strong Buy